Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study.
To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal cell carcinoma (mRCC).A total of 177 mRCC patients using sorafenib as first- (N = 116), second- (N = 43), and third-line (N = 18) therapies were enrolled from 11 Korean centers between 2006 and 2012. The patie...
Main Authors: | Sung Han Kim, Sohee Kim, Byung-Ho Nam, Sang Eun Lee, Choung Soo Kim, Ill Young Seo, Tae Nam Kim, Sung-Hoo Hong, Tae Gyun Kwon, Seong Il Seo, Kwan Joong Joo, Kanghyon Song, Cheol Kwak, Jinsoo Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4550402?pdf=render |
Similar Items
-
Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
by: Jae Young Park, et al.
Published: (2020-05-01) -
Establishment of Korean prostate cancer database by the Korean Urological Oncology Society
by: Hanjong Ahn, et al.
Published: (2017-11-01) -
Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
by: Jung Kwon Kim, et al.
Published: (2019-07-01) -
Data sharing attitudes and practices of researchers in Korean government research institutes: a survey-based descriptive study
by: Jihyun Kim, et al.
Published: (2023-02-01) -
Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
by: Seung Il Jung, et al.
Published: (2020-01-01)